Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating featuresChad J. Creighton, Jenny C. Chang, Xiaoxian Li et al.|Proceedings of the National Academy of Sciences|2009Cited by 1.4k
A Renewable Tissue Resource of Phenotypically Stable, Biologically and Ethnically Diverse, Patient-Derived Human Breast Cancer Xenograft ModelsXiaomei Zhang, Michael T. Lewis, Sofie Claerhout et al.|Cancer Research|2013Cited by 485
A SUMOylation-Dependent Transcriptional Subprogram Is Required for Myc-Driven TumorigenesisJessica D. Kessler, Thomas F. Westbrook, Kristopher T. Kahle et al.|Science|2011Cited by 440
Medical Complications and Outcomes After Hip Fracture RepairValerie A. Lawrence, Jeffrey L. Carson, Susan G. Hilsenbeck et al.|Archives of Internal Medicine|2002Cited by 374
Activation of Multiple Proto-oncogenic Tyrosine Kinases in Breast Cancer via Loss of the PTPN12 PhosphataseTingting Sun, Thomas F. Westbrook, Nicola Aceto et al.|Cell|2011Cited by 276